Licensing Opportunities

  • Antigen Mixtures for Serological Detection of HHV-8 Infection
    •
       Ref: E-063-2009-0 | Updated: May 6, 2018 | NIDCR
  • Diagnostic Assays and Methods of Use for Detection of Filarial Infection
    •
       Ref: E-281-2010-0 | Updated: May 6, 2018 | NIAID
  • Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain
    •
       Ref: E-044-1998-0 | Updated: May 6, 2018 | NIDCR
  • Estrogen-related Receptor (ERR) and Proliferator-activated Receptor Gamma Coactivator (PGC)/ERR Reporter Stable...
    •
       Ref: E-224-2015-0 | Updated: May 4, 2018 | NIEHS
  • Human Monoclonal Antibodies Cross-reacting to Insulin-like Growth Factors IGF-I and IGF-II as Potential Anti-tumor...
    •
       Ref: E-068-2011 | Updated: May 4, 2018 | NCI
  • Human T Cell Receptors for Treating Cancer
    •
       Ref: E-269-2010 | Updated: May 4, 2018 | NCI
  • MDCK Cells with Enhanced Characteristics for Vaccine and Virus Production
    •
       Ref: E-173-2008-0 | Updated: May 4, 2018 | NIDDK
  • Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and...
    •
       Ref: E-144-2012-0 | Updated: May 1, 2018 | NHGRI
  • Method of Diagnosing Multidrug Resistant Tuberculosis
    •
       Ref: E-093-2000-0 | Updated: May 1, 2018 | NIAID
  • Total Emission Detection System for Multi-Photon Microscopy
    •
       Ref: E-257-2005-0 | Updated: May 1, 2018 | NHLBI
  • Fatty Acid Derivatives and Their Use
    •    Ref: E-151-2017 | Updated: Apr 25, 2018 | NIA
  • Robotic Exoskeleton for Treatment of Crouch Gait in Children with Cerebral Palsy (CP)
    •
       Ref: E-096-2016 | Updated: Apr 25, 2018 | CC
  • High-Affinity Mouse Monoclonal Antibodies to GPC-3 for Liver Cancer Research
    •
       Ref: E-136-2012 | Updated: Apr 24, 2018 | NCI
  • Nitric Oxide Based Therapeutics for the Treatment of Lung Cancer
    •
       Ref: E-025-2010 | Updated: Apr 24, 2018 | NCI
  • Knockout and Conditional Knockout Mice-GPR116
    •    Ref: E-269-2012 | Updated: Apr 23, 2018 | NCI
  • Optical Trap Methods to Determine the Viscoelastic Properties of Biological Materials
    •
       Ref: E-251-2015 | Updated: Apr 23, 2018 |
  • Anti-Viral Compounds that Inhibit HIV Activity
    •
       Ref: E-081-2011 | Updated: Apr 20, 2018 | NCI
  • Diagnostic Marker for Improving Treatment Outcomes of Hepatitis C
    •    Ref: E-217-2011 | Updated: Apr 20, 2018 | NCI
  • Improved Antibodies Against ERBB4/HER4
    •
       Ref: E-171-2009 | Updated: Apr 20, 2018 | NICHD
  • Target for Anti-Tumor Immune Responses
    •
       Ref: E-070-2010 | Updated: Apr 19, 2018 |
  • Method and Device for Selectively Labeling RNA
    •
       Ref: E-119-2013 | Updated: Apr 18, 2018 | NCI
  • Peptide Mimetic Ligands of Polo-like Kinase 1 Polo Box Domain
    •
       Ref: E-094-2013 | Updated: Apr 18, 2018 | NCI
  • Software for Accurate Segmentation of Cell Nuclei in Breast Tissue
    •
       Ref: E-106-2010 | Updated: Apr 18, 2018 | NCI
  • B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia
    •
       Ref: E-163-2009 | Updated: Apr 17, 2018 | NCI
  • Method for Generating Pluripotent and Multipotent Cells
    •
       Ref: E-086-2012 | Updated: Apr 17, 2018 | NCI
  • Vaccines for HIV
    •
       Ref: E-087-2015 | Updated: Apr 17, 2018 | NCI
  • Prognostic Biomarkers for Patients with Early Stage Lung Cancer
    •    Ref: E-048-2012 | Updated: Apr 9, 2018 | NCI
  • Method and System of Building Hospital-Scale Medical Image Database
    •    Ref: E-076-2017 | Updated: Apr 4, 2018 | CC
  • Combination Cancer Therapy with HDAC Inhibitors
    •
       Ref: E-065-2016 | Updated: Apr 3, 2018 | NCI
  • Small Molecule Anti-cancer Agents that Stabilize the MYC-G-Quadruplex
    •
       Ref: E-053-2015 | Updated: Apr 3, 2018 | NCI
  • Therapeutics for Neurodegenerative Disorders and Cancer Using Lenalidomide Analogs
    •
       Ref: E-045-2012 | Updated: Apr 3, 2018 | NIA
  • Modified griffithsin tandemers for enhanced activity and reduced viral aggregation
    •
       Ref: E-034-2013 | Updated: Mar 29, 2018 | NCI
  • Nitroxyl (HNO) Releasing Therapeutics
    •
       Ref: E-019-2010 | Updated: Mar 29, 2018 | NCI
  • Ratio Based Biomarkers for the Prediction of Cancer Survival
    •
       Ref: E-025-2009 | Updated: Mar 29, 2018 | NCI
  • Chlamydial Vaccine Technologies
    •
       Ref: E-031-2006-0 | Updated: Mar 28, 2018 | NIAID
  • Mouse Xenograft Model for Mesothelioma
    •
       Ref: E-302-2009 | Updated: Mar 27, 2018 | NCI
  • Cancer Immunotherapy Using Virus-like Particles
    •
       Ref: E-050-2014 | Updated: Mar 26, 2018 | NCI
  • Novel Anti-HIV Proteins from Coral Reefs
    •
       Ref: E-295-2012 | Updated: Mar 26, 2018 | NCI
  • Chimeric Antigen Receptors (CARs) for Treating Lymphoma and Other Cancers
    •
       Ref: E-001-2016 | Updated: Mar 23, 2018 | NCI
  • Novel Tocopherol and Tocopheryl Quinone Derivatives as Therapeutics for Lysosomal Storage Disorders
    •
       Ref: E-148-2012-0 | Updated: Mar 22, 2018 | NCATS
  • Device to guide oxygen over cells for photo-oxidation
    •
       Ref: E-244-2016 | Updated: Mar 21, 2018 | NCI
  • Immunogenic Antigen Selective Cancer Immunotherapy
    •
       Ref: E-089-2009 | Updated: Mar 21, 2018 | NIA
  • Mobile Software for Substance Abuse Interventions and Behavioral Modification
    •    Ref: E-195-2012 | Updated: Mar 21, 2018 | NIDA
  • A New Class of Stable Heptamethine Cyanine Fluorophores and Biomedical Applications Thereof
    •
       Ref: E-271-2014 | Updated: Mar 20, 2018 | NCI
  • Brachyury-directed Vaccine for the Prevention or Treatment of Cancers
    •
       Ref: E-055-2011 | Updated: Mar 20, 2018 | NCI
  • Schweinfurthins and Uses Thereof
    •
       Ref: E-183-2009 | Updated: Mar 20, 2018 | NCI
  • Fully-human Heavy-chain-only Anti-B-cell Maturation Antigen (BCMA) Chimeric Antigen Receptors (CARs)
    •
       Ref: E-183-2017 | Updated: Mar 13, 2018 | NCI
  • Simple, Rapid, and Sensitive Real-Time PCR Assays for Detecting Drug Resistance of HIV
    •
       Ref: E-198-2013-0 | Updated: Mar 12, 2018 | CDC
  • Cell Lines Expressing Nuclear and/or Mitochondrial RNAse H1
    •
       Ref: E-273-2012 | Updated: Mar 9, 2018 | NICHD
  • Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia (GSD-Ia)
    •
       Ref: E-039-2015 | Updated: Mar 9, 2018 | NICHD
  • Improved Personalized Cancer Immunotherapy
    •
       Ref: E-059-2013 | Updated: Mar 9, 2018 | NCI
  • New Cancer Research Model: Spontaneously Transformed Mouse Epithelial Cancer Cell Lines
    •    Ref: E-089-2010 | Updated: Mar 9, 2018 | NCI
  • Human and Veterinary Cancer Therapeutic Agent Utilizing Anthrax Toxin-Based Technology
    •
       Ref: E-256-2015-0 | Updated: Feb 27, 2018 | NIAID
  • Near Real-time, Low-cost, Hand-held Sensors for Measuring Elemental Concentration of Airborne Particles for Indoor...
    •
       Ref: E-291-2016-0 | Updated: Feb 27, 2018 | CDC
  • Substituted Quinoline Analogs as Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors
    •
       Ref: E-101-2017-0 | Updated: Feb 27, 2018 | NCATS
  • NSAIDs that Assist the Treatment of Human Diseases
    •
       Ref: E-131-2011 | Updated: Feb 21, 2018 | NCI
  • Tissue Clamp for Repeated Opening and Closure of Incisions/Wounds
    •
       Ref: E-293-2016 | Updated: Feb 17, 2018 | NEI
  • A Novel Carbohydrate Antibody to GalNac1-3Gal and Its Application for Cancer Diagnostic and Prognosis
    •
       Ref: E-058-2009 | Updated: Feb 16, 2018 | NCI
  • Cancer-reactive T cells from Peripheral Blood
    •
       Ref: E-149-2015 | Updated: Feb 16, 2018 | NCI
  • Peptide Mimetic Ligands of Polo-like Kinase 1 Polo Box Domain (“Plk1 PBD Portfolio”)
    •
       Ref: E-181-2009 | Updated: Feb 16, 2018 | NCI
  • Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
    •
       Ref: E-293-2014-1 | Updated: Feb 14, 2018 | CDC
  • Personalized Cancer Evaluation (PERCEVAL) Method and Software
    •
       Ref: E-289-2016-0 | Updated: Feb 14, 2018 | CDC
  • Monoclonal Antibodies for Specific Detection of Dengue Virus Sub-type 4 in Human Serum
    •
       Ref: E-057-2016-0 | Updated: Feb 12, 2018 | CDC
  • Rapid Colorimetric Detection of Zika Virus from Serum and Urine Specimens by RT-LAMP (Reverse Transcription Loop-...
    •
       Ref: E-041-2017-0 | Updated: Feb 8, 2018 | CDC
  • Rat Model for Alzheimer's Disease
    •
       Ref: E-211-2012-0 | Updated: Feb 7, 2018 | NIMH
  • Agonistic Human Monoclonal Antibodies against Death Receptor 4 (DR4)
    •
       Ref: E-158-2010 | Updated: Feb 5, 2018 | NCI
  • Chimeric Antibodies Against Hepatitis B e-Antigen
    •
       Ref: E-192-2017-0 | Updated: Jan 31, 2018 | NIAMS
  • Regenerative Therapy for Cartilage Damage
    •
       Ref: E-152-2017-0 | Updated: Jan 25, 2018 | NIDCR
  • IL7Rα-Specific Antibody for Treating Acute Lymphoblastic Leukemia (ALL)
    •
       Ref: E-247-2015 | Updated: Jan 17, 2018 | NCI
  • Portable Laser-Operated Counterfeit Drug Identifier (CoDI) for Tablets
    •    Ref: E-572-2013-1 | Updated: Jan 17, 2018 | CDC
  • DNA Probes to Rapidly Screen Candida glabrata Isolates for Echinocandin Resistance to Antifungal...
    •
       Ref: E-132-2014-0 | Updated: Jan 9, 2018 | CDC
  • West Nile/Zika Virus Chimeras for Inactivated Zika Vaccine and Diagnostic Assay Development
    •    Ref: E-177-2016-0 | Updated: Dec 21, 2017 | CDC
  • Device for Growing Mammalian Cells on EM Grids
    •
       Ref: E-243-2016 | Updated: Dec 20, 2017 | NCI
  • Natural product-based anti-cancer agents: aza-Englerin analogues
    •
       Ref: E-090-2014 | Updated: Dec 20, 2017 | NCI
  • Methods of analyzing virus-derived therapeutics
    •
       Ref: E-240-2015 | Updated: Dec 19, 2017 | NCI
  • Processes for Producing and Purifying Nucleic Acid-Containing Compositions
    •
       Ref: E-267-2014 | Updated: Dec 17, 2017 | NCI
  • Monoclonal Antibody Specific for DNA/RNA Hybrid Molecules
    •
       Ref: E-738-2013-0 | Updated: Dec 15, 2017 | NIAID
  • MADCO-Accelerated Multidimensional Diffusion MRI
    •
       Ref: E-173-2016 | Updated: Dec 7, 2017 | NICHD
  • Novel Cancer Immunotherapy: A T Cell Receptor That Specifically Recognizes Common KRAS Mutations
    •
       Ref: E-028-2015 | Updated: Dec 7, 2017 | NCI
  • SLCO1B3 Genotyping to Predict a Survival Prognosis of Prostate Cancer
    •
       Ref: E-083-2007 | Updated: Dec 7, 2017 |
  • Plasmids Encoding and Producing Anthrax Toxin Proteins
    •
       Ref: E-059-2008-0 | Updated: Dec 6, 2017 | NIAID
  • Methods of Producing Effective T-cell Populations Using Akt Inhibitors
    •
       Ref: E-013-2016 | Updated: Dec 5, 2017 | NCI
  • Real-Time PCR Assay for Detection of Carbapenem Antibiotic Resistance Genes of the IMP-type
    •    Ref: E-156-2017-0 | Updated: Dec 5, 2017 | CDC
  • Conformation Dependent Anti-major Outer Membrane Protein (MOMP) Monoclonal Antibody BD5
    •
       Ref: E-296-2007-0 | Updated: Dec 4, 2017 | NIAID
  • CXCR1 - Human IL-8 Receptor cDNA
    •
       Ref: B-004-1995-0 | Updated: Dec 4, 2017 | NIAID
  • Human CC Chemokine Receptor CX3CR1 / CMKBRL1 cDNA
    •
       Ref: B-037-1995-6 | Updated: Dec 4, 2017 | NIAID
  • Human CCR2 cDNA
    •
       Ref: B-008-1998-0 | Updated: Dec 4, 2017 | NIAID
  • Human CCR3 cDNA
    •
       Ref: B-009-1998-0 | Updated: Dec 4, 2017 | NIAID
  • Human fMLP Receptor / FPR cDNA
    •
       Ref: B-007-1995-0 | Updated: Dec 4, 2017 | NIAID
  • Human FPRL1 / FPR2 cDNA
    •
       Ref: B-008-1995-0 | Updated: Dec 4, 2017 | NIAID
  • Human Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) cDNA
    •
       Ref: B-005-1995-0 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 25-D1.16 Producing Monoclonal Anti-H-2Kb/SIINFEKL Complex Antibody
    •
       Ref: B-006-1999-0 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 273 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp70
    •
       Ref: B-059-1994-0 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 3C7 Producing Monoclonal Anti-mouse CD25 (IL-2 receptor, alpha chain) Antibody
    •
       Ref: B-004-1991-1 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 500 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp80
    •
       Ref: B-059-1994-1 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 715 Producing Monoclonal Antibody Specific for Murine Leukemia Virus gp70
    •
       Ref: B-059-1994-2 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line 7D4 Producing Monoclonal Anti-mouse CD25 (IL-2 receptor) Antibody
    •
       Ref: B-004-1991-0 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line B6GE1, Monoclonal Antibody to the Specific Peptide-MHC Class II Complex
    •
       Ref: B-020-1999-0 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line D7 Producing Monoclonal Anti-mouse Ly-6A/E (Sca-1) Antibody
    •
       Ref: B-004-1991-2 | Updated: Dec 4, 2017 | NIAID
  • Hybridoma Cell Line D8H21, Monoclonal Antibody to the Specific Peptide-MHC Class II Complex
    •
       Ref: B-021-1999-0 | Updated: Dec 4, 2017 | NIAID

    Pages


    Displaying 501 - 600 of 1372

    Category Index

    Office of Technology Transfer, Office of Intramural Research, National Institutes of Health

    6011 Executive Blvd, Suite 325, Rockville, MD 20852 | Phone: 301-496-7057